About half of people with myasthenia gravis (MG) experience symptoms of urinary incontinence, while about one-third have signs of an overactive bladder, with an urgent need to urinate. That’s according to a recent study in Israel, which also found that patients with late-onset MG had a higher prevalence of…
News
Some people with well-controlled myasthenia gravis (MG) may be able to stop azathioprine or mycophenolate mofetil after a prolonged period of stable disease, though relapse remains possible, a small single-center real-world study suggests. The study, “Prognosis After Discontinuation of Azathioprine or Mycophenolate Mofetil in Well-Controlled…
Thymectomy, the surgical removal of the thymus, may be an effective therapeutic option for people with late-onset myasthenia gravis (LOMG) without increasing the risk of surgical complications. That’s according to a study in China, which also demonstrated that LOMG patients who underwent the surgical procedure were about 2.4…
New research reveals that race and ethnicity significantly influence how myasthenia gravis (MG) manifests in U.S. patients, with African American and Hispanic individuals developing the autoimmune condition at much younger ages and experiencing more severe initial symptoms. The study, drawing from two large national databases, highlights a stark divide…
The U.S. Food and Drug Administration (FDA) granted priority review to Argenx’s application seeking to expand the approval of Vyvgart (efgartigimod alfa-fcab) to adults with generalized myasthenia gravis (gMG) who test negative for anti-acetylcholine receptor (AChR) antibodies. If the supplemental biologics license application is approved, the infusion…
Dysphagia, or difficulty swallowing, is highly prevalent in people with myasthenia gravis (MG) and may be associated with severe complications, including lung infections caused by food aspiration into the airways. That is according to a review of studies assessing dysphagia in MG patients using objective instrumental tests and subjective…
Women with myasthenia gravis (MG) have a higher risk of pregnancy complications, particularly preeclampsia, and their babies are more likely to be born prematurely and small for their gestational age, according to a study in the U.S. Preeclampsia is a serious pregnancy complication marked by new-onset high blood pressure…
Starting rituximab earlier after the onset of generalized myasthenia gravis (gMG) may be associated with better long-term outcomes, including fewer hospital admissions due to disease worsening and the need for rescue treatments. That’s according to up to five-year results from a follow-up study of participants in the…
Vyvgart (efgartigimod) combined with a low 250 mg dose of the glucocorticoid methylprednisolone may offer a safer and equally effective treatment option for people with severe generalized myasthenia gravis (gMG), according to a new study from China. gMG patients treated with this combination showed comparable reductions in disease severity…
In 2025, Myasthenia Gravis News delivered readers timely reporting on research, treatments, and clinical trials for myasthenia gravis (MG). We have compiled the 10 most-read stories for a recap of the year, each accompanied by a brief summary. As we enter 2026, we look forward to continuing our…
Recent Posts
- My twin’s diet changes again after a lactose intolerance diagnosis
- The dangers of misinformation in a world that craves certainty
- Being silent about my MG symptoms is like wearing a mask
- Urinary incontinence may affect about half of MG patients: Study
- New study explores when MG patients can taper immunosuppressive therapy